Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.130
-0.010 (-0.88%)
Feb 27, 2026, 4:00 PM EST - Market closed
Lite Strategy Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
41.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 65.30M | 16.48M | 33.76% |
| Jun 30, 2023 | 48.82M | 8.12M | 19.95% |
| Jun 30, 2022 | 40.70M | 5.90M | 16.96% |
| Jun 30, 2021 | 34.80M | 7.04M | 25.36% |
| Jun 30, 2020 | 27.76M | 22.84M | 464.72% |
| Jun 30, 2019 | 4.92M | 3.29M | 203.02% |
| Jun 30, 2018 | 1.62M | -21.63M | -93.02% |
| Jun 30, 2017 | 23.25M | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | - | - | - |
| Jun 30, 2014 | - | - | - |
| Jun 30, 2013 | - | - | - |
| Jun 30, 2012 | - | - | - |
| Jun 30, 2011 | - | - | - |
| Jun 30, 2010 | - | - | - |
| Jun 30, 2009 | - | - | - |
| Jun 30, 2008 | 674.00K | 29.00K | 4.50% |
| Jun 30, 2007 | 645.00K | 199.00K | 44.62% |
| Jun 30, 2006 | 446.00K | 138.00K | 44.81% |
| Jun 30, 2005 | 308.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 31.80M |
| Veru Inc. | 16.89M |
| NovaBay Pharmaceuticals | 10.30M |
| Apollomics | 6.93M |
| CervoMed | 6.16M |
| Lisata Therapeutics | 1.07M |
LITS News
- 11 days ago - Lite Strategy Reports Fiscal 2026 Second Quarter Results - GlobeNewsWire
- 6 months ago - MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS' - Business Wire
- 7 months ago - MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
- 7 months ago - BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode - TheNewswire
- 7 months ago - MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 8 months ago - Why Is MEI Pharma Stock Soaring On Friday? - Benzinga
- 8 months ago - MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
- 10 months ago - MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - Business Wire